申请人:Eli Lilly and Company
公开号:US05962474A1
公开(公告)日:1999-10-05
This invention provides novel 5-HT.sub.1F agonists of Formula I ##STR1## where A--B, R,R.sup.1 and X are as defined in the specification, which are useful for the treatment of migraine and associated disorders.
本发明提供了式I的新型5-HT.sub.1F激动剂:##STR1## 其中A-B、R、R.sup.1和X如规范中所定义,这些激动剂对于治疗偏头痛及其相关疾病是有用的。